Use of apomorphine

PDMED_APOMORPHINE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04BC07

17

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

11

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

11

diagram downward connector

Include endpoints None

11

diagram downward connector
PDMED_APOMORPHINE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 11 5 6
Unadjusted prevalence (%) 0.00 0.00 0.00
Mean age at first event (years) 65.19 63.87 66.28

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: PDMED_APOMORPHINE – Use of apomorphine
GWS hits:

Survival analyses between endpoints

Plot

before Use of apomorphine
after Use of apomorphine

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of apomorphine